A
Arun Richard Chandrasekaran
Researcher at State University of New York System
Publications - 80
Citations - 2231
Arun Richard Chandrasekaran is an academic researcher from State University of New York System. The author has contributed to research in topics: DNA nanotechnology & DNA origami. The author has an hindex of 22, co-authored 80 publications receiving 1465 citations. Previous affiliations of Arun Richard Chandrasekaran include New York University & University of Madras.
Papers
More filters
Journal ArticleDOI
Rationally Engineered Nucleic Acid Architectures for Biosensing Applications.
TL;DR: A review of various nucleic acid-based biosensors, the different read-out strategies employed, and their use in chemical and biological sensing and how rational design of such constructs leads to more efficient biosensing platforms.
Journal ArticleDOI
Fabrication of a nanofibrous scaffold with improved bioactivity for culture of human dermal fibroblasts for skin regeneration.
Arun Richard Chandrasekaran,Jayarama Reddy Venugopal,Subramanian Sundarrajan,Seeram Ramakrishna +3 more
TL;DR: The obtained results prove that the plasma-treated PLACL/gelatin nanofibrous scaffold is a potential biocomposite material for skin tissue regeneration.
Journal ArticleDOI
An Update on Nanomaterials-Based Textiles for Protection and Decontamination
TL;DR: In this paper, metal oxide nanoparticles (MONPs) such as TiO2 and MgO are used as potential catalysts for the decontamination of chemical and biological warfare agents.
Journal ArticleDOI
Nuclease resistance of DNA nanostructures.
TL;DR: This Review discusses the approaches used to modulate and evaluate the nuclease resistance of DNA nanostructures and provides an overview of the techniques employed to evaluate resistance to degradation and quantify stability.
Journal ArticleDOI
DNA Nanocarriers: Programmed to Deliver
Bharath Raj Madhanagopal,Shunqing Zhang,Esra Demirel,Heitham Wady,Arun Richard Chandrasekaran +4 more
TL;DR: The strategies used to transform DNA nanostructures into drug delivery vehicles are discussed and the challenges that lay ahead for these synthetic vectors as they set new paradigms in the field of nanotechnology and medicine are presented.